Cargando…
Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia
Familial hypocalciuric hypercalcemia (FHH, [OMIM #145980]) is recognized as a benign endocrine condition affecting PTH and calcium levels due to heterozygous inactivating mutations in the calcium sensing receptor (CaSR). The condition is often un- or misdiagnosed but may have a prevalence as high as...
Autores principales: | Höppner, Jakob, Lais, Sabrina, Roll, Claudia, Wegener-Panzer, Andreas, Wieczorek, Dagmar, Högler, Wolfgang, Grasemann, Corinna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518617/ https://www.ncbi.nlm.nih.gov/pubmed/34659108 http://dx.doi.org/10.3389/fendo.2021.700612 |
Ejemplares similares
-
Disorders of the Calcium Sensing Signaling Pathway: From Familial Hypocalciuric Hypercalcemia (FHH) to Life Threatening Conditions in Infancy
por: Höppner, Jakob, et al.
Publicado: (2022) -
MON-258 Toddler with Hypercalcemia: Diagnosis of Familial Hypocalciuric Hypercalcemia
por: Kochanski, Justin, et al.
Publicado: (2019) -
Severe Symptomatic Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia
por: Kurian, Roshini, et al.
Publicado: (2021) -
Calcimimetic Use in Familial Hypocalciuric Hypercalcemia—A Perspective in Endocrinology
por: Marx, Stephen J.
Publicado: (2017) -
A Case of Lithium-Associated Hypocalciuric Hypercalcemia
por: Nwabufor, Philip C, et al.
Publicado: (2020)